POLQ and cancer: The underlying mechanism of this loss of increased PD-L1 expression is likely decreased POLQ expression in BRCA-reconstituted (i.e., HR-proficient) cancer cells (Supplementary Fig. 1e, f), which correlates with decreased sensitivity to NVB-mediated POLθ inhibition7,8.